BioNexus Gene Lab Corp. (BGLC) vs PTL Limited (PTLE)

A side-by-side comparison of BioNexus Gene Lab Corp. and PTL Limited across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
BioNexus Gene Lab Corp. logo
BGLC
BioNexus Gene Lab Corp.
$3M
$1.24IndustrialsDelayed quote: Oct 6, 2026, 12:50 PM EDT
PTL Limited logo
PTLE
PTL Limited
$3M
$7.05IndustrialsDelayed quote: Oct 6, 2026, 12:48 PM EDT

Total return — BGLC vs PTLE

growth of $100 · dividends reinvested · last 2y
BGLC -67.1% (-42.6%/yr)PTLE -97.8% (-85.3%/yr)BGLC compounded faster over this window
Log scale — wide-divergence pair
1101001kStart $10020252026$33$2
BGLC PTLE

BGLC vs PTLE: by the numbers

  • •BGLC is the larger company ($3M vs $3M market cap).
  • •Both run net losses; PTLE's is the smaller (-1.65% vs -82.36% net margin).

Metrics side by side

Valuation

MetricBGLCPTLE
P/S ratio0.96N/A
P/B ratio0.392.60

Profitability

MetricBGLCPTLE
Gross margin11.64%1.27%
Operating margin-42.54%-0.62%
Net margin-82.36%-1.65%
ROE-33.11%-13.25%
ROIC-32.71%-4.97%

Growth (annualized)

MetricBGLCPTLE
Revenue CAGR (5Y)-31.68%N/A
Total return CAGR (5Y)-61.00%N/A

Go deeper

Full BGLC analysisFull PTLE analysisInteractive comparison tool

Dig into the metrics

BioNexus Gene Lab ROEPTL ROEBioNexus Gene Lab operating marginPTL operating marginBioNexus Gene Lab revenue growthPTL revenue growthBioNexus Gene Lab free cash flowPTL free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.